SEC Form D filing

Ollin Biosciences, Inc.

Biotech · Growth · Regulation D 506(b) · TX · Filed June 24, 2026

Offering amount: $330.0M
Exemption: Reg D 506(b)
Issuer state: TX
Filing date: June 24, 2026
Signature date: June 24, 2026
CIK: 0002141184

Summary

Auto-generated

The issuer's name indicates a biotechnology focus, placing it in the biotech vertical. The Texas-based corporation filed a Rule 506(b) offering for $330.0 million on June 24, 2026.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.